Physician
Pathology
Dr. Phuong Nguyen, MD
|
|
Give Review
Phuong Nguyen, MD practices Pathology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care Phuong Nguyen, MD is also a published physician. He has 62 paper published. The most recent paper is: False-negative rates of tumor metastases in the histologic examination of bone marrow. Phuong Nguyen accepts all Medicare patients.
Publications
- Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
- Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.
- Patients' rationale for declining participation in a Cancer-associated weight loss study.
- Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia.
- Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation.
- Self-organization of stabilized microtubules by both spindle and midzone mechanisms in Xenopus egg cytosol.
- Nonsteroidal Anti-inflammatory Drug and Acetaminophen Use and Risk of Adult Myeloid Leukemia.
- Practical Strategies to Circumvent and/or Surmount Six Barriers in Health Disparities Research: Observations from a Pilot Project Among Vietnamese Americans.
- Former Military Officers from the Republic of Vietnam Now Living in the United States (US): Exploring their Perceptions of the US Healthcare System.
- A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors.
- Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
- The myelodysplastic syndromes.
- Do patients die from rashes from epidermal growth factor receptor inhibitors? A Systematic review to help counsel patients about holding therapy.
- Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance.
- A placebo-controlled double blind trial of etanercept for the Cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
- WHIM syndrome.
- Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
- Interleukin-1 genetic polymorphisms and their relationship to the Cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
- Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota.
- Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central Cancer treatment group.
- CD4+ T cell depletion during all stages of HIV Disease occurs predominantly in the gastrointestinal tract.
- Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate.
- Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome.
- Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia.
- On appetite and its loss.
- Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.
- The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
- Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.
- SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress.
- Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung Cancer.
- CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
- Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells.
- Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma.
- Interpreting flow cytometry for hematologic Neoplasms.
- Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.
- Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin.
- SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression.
- BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.
- Chromosomal protein HMGN1 modulates the expression of N-cadherin.
- Can pathology residents be trained to perform adequate bone marrow biopsies?
- Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable.
- Surveying technologists: a novel method for establishing productivity standards in a clinical haematology laboratory.
- False-negative rates of tumor metastases in the histologic examination of bone marrow.
- DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells.
- Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's Disease: a comparative immunohistochemical study.
- Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia.
- Redox-sensitive signaling factors as a novel molecular targets for Cancer therapy.
- Increased lymphoblast-like cells following umbilical cord blood stem cell transplantation do not predict recurrent acute leukemia.
- Thioredoxin reductase as a novel molecular target for Cancer therapy.
- G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.
- Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.
- Prognostic variables in male breast Cancer.
- Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice.
- Bone Pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting?
- Side effects and pharmaceutical company bias: adverse event reporting in Cancer supportive and palliative care trials.
- Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.
- Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
- Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
- Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
- A placebo-controlled, double-blind trial of infliximab for Cancer-associated weight loss in elderly and/or poor performance non-small cell lung Cancer patients (N01C9).
- Is bortezomib, a proteasome inhibitor, effective in treating Cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
Graduate Hospital
Ucimc
Procedures Preformed
- Biliary Drainage
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Pathology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Power Select HMO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select Plus HMO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Cigna HMO
- Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Delta Health System
- GEHA
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- Humana
- Kaiser Permanente
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Optima Health
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Education
-
University of Minnesota at Fairview -
Massachusetts General Hospital -
Johns Hopkins University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1801838750 | |
| NPPES Provider LastName | NGUYEN | |
| NPPES Provider FirstName | PHUONG | |
| NPPES Provider ZIPCode | 926633509 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 47.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801838750 |
| Last Name Of The Provider | NGUYEN |
| First Name Of The Provider | PHUONG |
| View All |
Similar Doctors
|
|
Dr. Norman H. Bain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn D. Madokoro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parminder Dhaliwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shih-Ting P. Tsai, MD |
|
|
Dr. Julie G. Duquette, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas R. Heinz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis S. Heinemann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nazila Zekry Armand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veronica Rausei-Mills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arell Shapiro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet M. Stallman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhay S. Parikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lino J. Deguzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Schiffer, MD
This Doctor is OpenDoctor Recommended.
|